Bluejay Diagnostics (BJDX) EPS (Weighted Average and Diluted) (2021 - 2026)
Bluejay Diagnostics recorded quarterly EPS (Weighted Average and Diluted) of -$1.95 in Q1 2026, up 81.66% quarter-over-quarter from -$10.63 in Q4 2025, and up 85.51% year-over-year from -$1.05 in Q1 2025.
Bluejay Diagnostics' EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$1.95 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 85.51% year-over-year to -$1.95; the TTM figure through Mar 2026 stood at -$15.0 (up 97.12% YoY), while the FY2025 annual figure was -$15.25, up 96.66% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$1.95 for Q1 2026 at Bluejay Diagnostics, up from -$10.63 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.1 in Q1 2022 to a low of -$3573.1 in Q4 2023.
- A 5-year average of -$267.78 and a median of -$10.63 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) plunged 146719.67% in 2023 and surged 99.45% in 2025, its largest moves.
- Bluejay Diagnostics' EPS (Weighted Average and Diluted) stood at -$2.43 in 2022, then plunged by 146719.67% to -$3573.1 in 2023, then jumped by 95.14% to -$173.57 in 2024, then soared by 93.88% to -$10.63 in 2025, then soared by 81.66% to -$1.95 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$1.95, -$10.63, and -$1.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -1.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.95 |
| Dec 31, 2025 | -10.63 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -1.41 |
| Mar 31, 2025 | -13.46 |
| Dec 31, 2024 | -173.57 |
| Sep 30, 2024 | -76.94 |
| Jun 30, 2024 | -256.16 |
| Mar 31, 2024 | -394.76 |
| Dec 31, 2023 | -3,573.10 |
| Sep 30, 2023 | -16.67 |
| Jun 30, 2023 | -22.75 |
| Mar 31, 2023 | -2.49 |
| Dec 31, 2022 | -2.43 |
| Sep 30, 2022 | -2.79 |
| Jun 30, 2022 | -1.97 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -0.16 |
| Sep 30, 2021 | -0.09 |
| Jun 30, 2021 | -0.16 |